article thumbnail

What factors are driving life sciences FDI in 2022?

Pharmaceutical Technology

Locating a subsidiary in close proximity to such an institution has advantages beyond pipeline talent, as there is the potential to access research and tap into networks for product development and clinical trials. Industry clusters. Locations with access to the sea may also offer a cheaper way of transporting goods.

article thumbnail

How one pharma “family business” places patients first

pharmaphorum

The status isn’t awarded lightly and Chiesi is the largest pharmaceutical manufacturer to be named a B Corp. “We In 2014, he founded Chiesi Ventures as a joint venture with Pappas Capital, an established life science venture capital fund, where he currently serves as Managing Partner.

article thumbnail

Call to arms as UK falls back in medicines manufacturing

pharmaphorum

Drastic steps need to be taken if the UK is to reverse a steep decline in medicines manufacturing in recent years, according to a cross-industry coalition. ” Image from the Association of the British Pharmaceutical Industry (ABPI).